<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="3462e28b-ef66-4de5-9944-b84022079cac"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Frédéric Chopin — True-date frame: synthetic events are moved into the patient&apos;s historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.</title>
  <effectiveTime value="18380515120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="c442dd1f-1923-4ee2-bc3d-c92f8dffad99"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="3b7655ed-b522-485f-ade3-a54d9884e453" extension="HR-NI020-SYN-TD"/>
      <id root="2.16.840.1.113883.4.1" extension="000-20-8845"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Frédéric</given><family>Chopin</family></name>
        <administrativeGenderCode code="M" codeSystem="2.16.840.1.113883.5.1" displayName="Male"/>
        <birthTime value="18100301"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="18380515120000-0500"/>
    <assignedAuthor><id root="138b4347-1894-46c1-b2d0-01900affe467"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Matthias</given><family>Lindqvist</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="18380515120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="138b4347-1894-46c1-b2d0-01900affe467"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Matthias</given><family>Lindqvist</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="18380515"/><high value="18380515"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="138b4347-1894-46c1-b2d0-01900affe467"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Matthias</given><family>Lindqvist</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="9aa3a68c-6a6c-478b-aeea-8e06c7886318"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>End of the eight-week intensive phase: susceptibility results, the two-month sputum culture, and the start of the continuation phase</originalText></code>
      <effectiveTime><low value="18380515"/><high value="18380515"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="138b4347-1894-46c1-b2d0-01900affe467"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Matthias</given><family>Lindqvist</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>End of the eight-week intensive phase. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Mr. Chopin completed the 56 doses of the intensive phase yesterday, all observed by video within eight weeks, and pyrazinamide has stopped; from today he takes rifapentine, moxifloxacin, isoniazid, and pyridoxine for nine more weeks. The isolate is susceptible to rifampin, isoniazid, pyrazinamide, and moxifloxacin. The cultures from the third week show no growth at six weeks. His cough has gone except for a little phlegm on waking, and he has gained 3.5 kg since diagnosis. He has no tendon pain, tingling, yellowing, or rash. He is teaching twelve students a week and has told them about his illness; none has left. The health department tells him the investigation of his contacts is going well, without giving him details. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>Treatment</td><td>56 of 56 intensive-phase doses observed; continuation phase from today</td></tr><tr><td>Susceptibility</td><td>Susceptible to rifampin, isoniazid, pyrazinamide, and moxifloxacin</td></tr><tr><td>Cultures</td><td>Third-week cultures negative at six weeks</td></tr><tr><td>Weight</td><td>52.0 kg, up 3.5 kg</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Respiratory</td><td>Positive</td><td>A little phlegm on waking; no cough during the day; no blood</td></tr><tr><td>Constitutional</td><td>Negative</td><td>No fever or night sweats; appetite good</td></tr><tr><td>Musculoskeletal</td><td>Negative</td><td>No tendon pain</td></tr><tr><td>Neurological</td><td>Negative</td><td>No numbness or tingling</td></tr><tr><td>Psychiatric</td><td>Negative</td><td>Mood good; PHQ-9 4; no thoughts of suicide or self-harm</td></tr></tbody></table><paragraph>5 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Rifapentine 150 mg tablets, eight tablets (1200 mg) daily with food</td><td>1200 mg once daily with a meal by video-observed therapy with the health department, seven days a week, for 17 weeks (119 doses)</td><td>Oral route</td><td>1838-03-20 to 1838-07-16</td><td>completed</td><td>S</td></tr><tr ID="medication-2"><td>Moxifloxacin 400 mg tablet, one tablet daily</td><td>400 mg once daily with the other drugs by video-observed therapy with the health department, seven days a week, for 17 weeks; no mineral supplements within 4 hours before or 8 hours after</td><td>Oral route</td><td>1838-03-20 to 1838-07-16</td><td>completed</td><td>S</td></tr><tr ID="medication-3"><td>Isoniazid 300 mg tablet, one tablet daily</td><td>300 mg once daily by video-observed therapy with the health department, seven days a week, for 17 weeks</td><td>Oral route</td><td>1838-03-20 to 1838-07-16</td><td>completed</td><td>S</td></tr><tr ID="medication-4"><td>Pyrazinamide 500 mg tablets, two tablets (1000 mg) daily</td><td>1000 mg once daily by video-observed therapy with the health department, seven days a week, for the eight-week intensive phase (weight band 40 to under 55 kg)</td><td>Oral route</td><td>1838-03-20 to 1838-05-14</td><td>completed</td><td>S</td></tr><tr ID="medication-5"><td>Vitamin B6 (pyridoxine) 50 mg tablet, one tablet daily</td><td>50 mg once daily with isoniazid</td><td>Oral route</td><td>1838-03-20 to 1838-07-16</td><td>completed</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="1748953d-e4e2-4efb-bf30-36ad3cedfe24"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="18380320"/><high value="18380716"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1200" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="242671" codeSystem="2.16.840.1.113883.6.88" displayName="rifapentine 150 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="4fa33ec2-6bef-447c-afbd-6b1b33d7e15d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="d5a591a9-acc9-441c-a2be-855ea6227b4b"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="18380320"/><high value="18380716"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="400" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="311787" codeSystem="2.16.840.1.113883.6.88" displayName="moxifloxacin 400 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="adfc8759-8cae-4e9a-8c22-086b346bccd9"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="dbda3077-514d-4a45-b836-3a9096acdfb7"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="18380320"/><high value="18380716"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="300" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="197832" codeSystem="2.16.840.1.113883.6.88" displayName="isoniazid 300 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="bf19d6d8-4202-4038-aec3-d79599caf92d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="fb6ba3b2-daaa-4b55-94e0-31fa689722a7"/>
      <text><reference value="#medication-4"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="18380320"/><high value="18380514"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1000" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198181" codeSystem="2.16.840.1.113883.6.88" displayName="pyrazinamide 500 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="c9d7dd8e-5e3d-459b-bb76-d68001f23f4b"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="ed86835c-155c-48a8-b94e-22413c68343a"/>
      <text><reference value="#medication-5"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="18380320"/><high value="18380716"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="50" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="639566" codeSystem="2.16.840.1.113883.6.88" displayName="vitamin B6 50 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="7b665376-b799-4123-956f-f5a59e6359d8"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="78a9fd2d-c0eb-4857-b6b9-9132b17cd613"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="18380317"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="d808b674-30a3-4594-84d3-0f92e9346e08"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-4-1"><td>1838-05-15</td><td>Body height</td><td>170</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-4-2"><td>1838-05-15</td><td>Body weight</td><td>52</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-4-3"><td>1838-05-15</td><td>Body mass index (BMI) [Ratio]</td><td>18</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-4-4"><td>1838-05-15</td><td>Systolic blood pressure</td><td>108</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-4-5"><td>1838-05-15</td><td>Diastolic blood pressure</td><td>68</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-4-6"><td>1838-05-15</td><td>Heart rate</td><td>78</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-4-7"><td>1838-05-15</td><td>Respiratory rate</td><td>16</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-4-8"><td>1838-05-15</td><td>Body temperature</td><td>36.8</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-4-9"><td>1838-05-15</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>98</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="b5ecc549-41ee-4dd2-923b-e408be7782a0"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="18380515"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="67e2abe7-53b8-45e0-bce3-6862e462944f"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-4-1"/></text><statusCode code="completed"/><effectiveTime value="18380515"/><value xsi:type="PQ" value="170" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="bad00c5f-594e-4964-8a4c-f08db90b27e9"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-4-2"/></text><statusCode code="completed"/><effectiveTime value="18380515"/><value xsi:type="PQ" value="52" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="fcabf70b-5d84-414c-8001-4f05315c786d"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-4-3"/></text><statusCode code="completed"/><effectiveTime value="18380515"/><value xsi:type="PQ" value="18" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="f8886bb5-7894-4de2-94a4-bd77b9fa538b"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-4-4"/></text><statusCode code="completed"/><effectiveTime value="18380515"/><value xsi:type="PQ" value="108" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="74154325-131d-490e-b463-924011f85604"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-4-5"/></text><statusCode code="completed"/><effectiveTime value="18380515"/><value xsi:type="PQ" value="68" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="00d7036c-b80c-4175-ba98-bb8bfb1d4110"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-4-6"/></text><statusCode code="completed"/><effectiveTime value="18380515"/><value xsi:type="PQ" value="78" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="38c665ec-ef3e-4765-803b-28fe2e32a4f4"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-4-7"/></text><statusCode code="completed"/><effectiveTime value="18380515"/><value xsi:type="PQ" value="16" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="8ad73ba5-4bc2-4a67-8a54-83de9e86a45f"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-4-8"/></text><statusCode code="completed"/><effectiveTime value="18380515"/><value xsi:type="PQ" value="36.8" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="4337af17-18d0-485a-8dcd-f498cac1ba77"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-4-9"/></text><statusCode code="completed"/><effectiveTime value="18380515"/><value xsi:type="PQ" value="98" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-22"><td>1838-05-15</td><td>Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma</td><td>29</td><td>U/L</td><td>7-56 U/L</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-23"><td>1838-05-15</td><td>Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma</td><td>27</td><td>U/L</td><td>10-40 U/L</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-24"><td>1838-05-15</td><td>Bilirubin.total [Mass/volume] in Serum or Plasma</td><td>0.6</td><td>mg/dL</td><td>0.1-1.2 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-25"><td>1838-05-15</td><td>Hemoglobin [Mass/volume] in Blood</td><td>13</td><td>g/dL</td><td>13.2-16.6 g/dL</td><td>Low</td><td>S</td></tr>
  <tr ID="result-26"><td>1838-05-15</td><td>Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]</td><td>4</td><td>{score}</td><td></td><td></td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="203c28f8-8c54-44eb-849b-8e506e244594"/>
      <code code="1742-6" codeSystem="2.16.840.1.113883.6.1" displayName="Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="18380515"/><high value="18380515"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="cf05617a-bdb7-4c5d-9039-dce08497a5a3"/>
          <code code="1742-6" codeSystem="2.16.840.1.113883.6.1" displayName="Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"/>
          <text><reference value="#result-22"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="18380515"/>
          <value xsi:type="PQ" value="29" unit="U/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>7-56 U/L</text>
              <value xsi:type="IVL_PQ"><low value="7" unit="U/L"/><high value="56" unit="U/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="aabb1d58-6691-4682-8e00-48c228ac05ee"/>
      <code code="1920-8" codeSystem="2.16.840.1.113883.6.1" displayName="Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="18380515"/><high value="18380515"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="200f7c28-1daf-4f08-be4f-80784d13fe36"/>
          <code code="1920-8" codeSystem="2.16.840.1.113883.6.1" displayName="Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"/>
          <text><reference value="#result-23"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="18380515"/>
          <value xsi:type="PQ" value="27" unit="U/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>10-40 U/L</text>
              <value xsi:type="IVL_PQ"><low value="10" unit="U/L"/><high value="40" unit="U/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="b9cf2a73-b38d-4097-bbb9-0a26e7f4ab41"/>
      <code code="1975-2" codeSystem="2.16.840.1.113883.6.1" displayName="Bilirubin.total [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="18380515"/><high value="18380515"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="ae2cdb4d-01a8-460a-b1b4-82588ff70842"/>
          <code code="1975-2" codeSystem="2.16.840.1.113883.6.1" displayName="Bilirubin.total [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-24"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="18380515"/>
          <value xsi:type="PQ" value="0.6" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>0.1-1.2 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="0.1" unit="mg/dL"/><high value="1.2" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="ddb58909-e850-4920-b743-9239198873bc"/>
      <code code="58410-2" codeSystem="2.16.840.1.113883.6.1" displayName="CBC panel - Blood by Automated count"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="18380515"/><high value="18380515"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="7fee64ad-583f-4a85-ad06-c49109eb8759"/>
          <code code="718-7" codeSystem="2.16.840.1.113883.6.1" displayName="Hemoglobin [Mass/volume] in Blood"/>
          <text><reference value="#result-25"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="18380515"/>
          <value xsi:type="PQ" value="13" unit="g/dL"/>
          <interpretationCode code="L" codeSystem="2.16.840.1.113883.5.83" displayName="Low"/>
          <referenceRange>
            <observationRange>
              <text>13.2-16.6 g/dL</text>
              <value xsi:type="IVL_PQ"><low value="13.2" unit="g/dL"/><high value="16.6" unit="g/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="ec7d6a2c-eb47-46ca-ab62-66395e78b23c"/>
      <code code="44261-6" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="18380515"/><high value="18380515"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="e89792ea-7cc2-4902-bea9-f267cec2ebcb"/>
          <code code="44261-6" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]"/>
          <text><reference value="#result-26"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="18380515"/>
          <value xsi:type="PQ" value="4" unit="{score}"/>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 1838-05-15; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Well; weight 52.0 kg</td></tr><tr><td>Eyes</td><td>No icterus</td></tr><tr><td>Respiratory</td><td>Clear apart from a few fine crackles at the right apex</td></tr><tr><td>Musculoskeletal</td><td>Tendons non-tender</td></tr><tr><td>Neurological</td><td>Normal sensation in the fingers and feet</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Cough for about three months, blood-streaked sputum for two weeks, night sweats, and weight loss of about 6 kg in a man of 28, with a right upper lobe cavity on chest X-ray and CT: suspected pulmonary tuberculosis; home airborne isolation and three sputum samples for acid-fast smear, nucleic acid amplification, and culture</td><td>resolved</td><td>confirmed</td>
    <td>R04.2</td><td>S — Synthetic presenting problem linked to his documented chronic cough and hemoptysis; superseded by the diagnosis at the second visit.</td>
  </tr>
  <tr ID="problem-2">
    <td>Pulmonary tuberculosis of the right upper lobe, cavitary and sputum smear-positive, confirmed by nucleic acid amplification without rifampin resistance</td><td>active</td><td>confirmed</td>
    <td>A15.0</td><td>S — Synthetic modern coding of his documented tuberculosis, chosen over the disputed genetic and cardiac alternatives; the cavity and all bacteriology are synthetic.</td>
  </tr>
  <tr ID="problem-3">
    <td>Moderate protein-calorie malnutrition: BMI 16.8, about 11 percent weight loss in three months, and albumin 3.2 g/dL</td><td>active</td><td>confirmed</td>
    <td>E44.0</td><td>S — Synthetic nutrition diagnosis anchored to his documented frailty and exhaustion.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="7273f904-2f9f-43fc-b51b-1de29ca555bc"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="18380317"/><high value="18380320"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="9c332de1-f7fc-49ea-ab9e-76c294ab655b"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="18380317"/><high value="18380320"/></effectiveTime>
          <value xsi:type="CD" code="R04.2" codeSystem="2.16.840.1.113883.6.90" displayName="Hemoptysis"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="5826947b-f17a-4a6e-b4df-c3d40173e109"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="18380320"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="79d9a1d2-506b-4e0b-91be-b36ea00b901d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="18380320"/></effectiveTime>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="a69a02e0-4185-4209-9b86-9d12a533fd2c"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="18380317"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="9f5a06f5-c136-4193-a6aa-27f81636c523"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="18380317"/></effectiveTime>
          <value xsi:type="CD" code="E44.0" codeSystem="2.16.840.1.113883.6.90" displayName="Moderate protein-calorie malnutrition"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Drug-susceptible pulmonary tuberculosis, continuation phase (A15.0)</content>. Intensive phase completed on time with a full clinical response. Liver tests normal (ALT 29, AST 27, bilirubin 0.6). Hemoglobin 13.0, up from 12.1. Dr. Kowalczyk-Grant reviewed the results by message and agrees with continuing. [S]<list><item>Rifapentine 1200 mg, moxifloxacin 400 mg, isoniazid 300 mg, and pyridoxine daily by video for 63 doses.</item><item>Two-month sputum smear and culture today, from the morning sample.</item></list></item><item><content styleCode="Bold">Moderate protein-calorie malnutrition (E44.0)</content>. Improving: BMI 18.0. [S]<list><item>Continue the supplements until his weight reaches 55 kg.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Examination</td><td>Symptom review: cough, sputum, hemoptysis, fever, night sweats</td><td>Every visit</td><td>Completed today</td><td>Morning phlegm only</td></tr><tr><td>Examination</td><td>Weight, with the pyrazinamide dose checked against the weight band</td><td>Monthly</td><td>Completed today</td><td>52.0 kg; pyrazinamide finished within its band</td></tr><tr><td>Medication safety</td><td>Adverse effects: hepatitis symptoms, tendon pain, numbness or tingling, rash, nausea, orange body fluids</td><td>Every visit</td><td>Completed today</td><td>None</td></tr><tr><td>Laboratory</td><td>Liver tests (ALT, AST, bilirubin)</td><td>Baseline; repeat for symptoms or risk factors (here at two to three weeks, for low weight and albumin)</td><td>Completed today</td><td>ALT 29, AST 27 U/L, bilirubin 0.6 mg/dL, all normal</td></tr><tr><td>Laboratory</td><td>Hemoglobin</td><td>When low at baseline</td><td>Completed today</td><td>13.0 g/dL, up from 12.1; anemia of inflammation resolving</td></tr><tr><td>Laboratory</td><td>Phenotypic susceptibility (rifampin, isoniazid, pyrazinamide, moxifloxacin)</td><td>At baseline</td><td>Completed today</td><td>Susceptible to rifampin, isoniazid, pyrazinamide, and moxifloxacin</td></tr><tr><td>Laboratory</td><td>Sputum acid-fast smear and culture</td><td>Baseline, then monthly until two consecutive cultures are negative</td><td>Completed today</td><td>Third-week cultures: no growth at six weeks (first negative culture)</td></tr><tr><td>Laboratory</td><td>Two-month sputum culture</td><td>At the end of the intensive phase; a positive result needs evaluation and repeat susceptibility testing</td><td>Completed today</td><td>Smear negative today; culture sent</td></tr><tr><td>Imaging</td><td>Chest X-ray</td><td>Baseline; at two months only if baseline cultures were negative; end of treatment optional</td><td>Not indicated</td><td>Not needed at two months, because the baseline cultures were positive</td></tr><tr><td>Medication safety</td><td>Doses observed and the completion clock (56 doses within 70 days, 63 within 84 days, 119 within five months)</td><td>Every visit</td><td>Completed today</td><td>56 doses in 56 days, within the 70-day limit</td></tr><tr><td>Referral</td><td>Contact investigation (students, friends, close contacts)</td><td>Led by the health department from diagnosis</td><td>Referred</td><td>Continuing with the health department; no results in his record</td></tr><tr><td>Survey</td><td>Depression screen (PHQ-9)</td><td>At diagnosis, at two months, and at the end of treatment</td><td>Completed today</td><td>4, item 9 scored 0</td></tr><tr><td>Self-management</td><td>Nutrition: dietitian, intake, supplement drinks</td><td>Every visit until weight is restored</td><td>Completed today</td><td>Supplements continue; eating well</td></tr><tr><td>Referral</td><td>Infectious diseases review</td><td>At diagnosis, at two months, and at the end of treatment</td><td>Completed today</td><td>Results reviewed by message today</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>Complete all 119 doses within five months by video-observed therapy. In progress; target 1838-07-21 [S]</item><item>Sputum culture negative at two months. In progress; target 1838-07-21 [S]</item><item>Return to teaching once the health department confirms he is no longer infectious. Outcome by 1838-04-07: Released from isolation after three negative smears and more than two weeks of treatment; teaching again from the third week [S]</item><item>Weight back to at least 55 kg by the end of treatment. In progress; target 1838-07-21 [S]</item><item>PHQ-9 below 5 by the end of treatment. In progress; target 1838-07-21 [S]</item></list><paragraph>Guideline basis: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016); Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis - United States, 2022 (2022); An official ATS statement: hepatotoxicity of antituberculosis therapy (2006); Guidelines for the investigation of contacts of persons with infectious tuberculosis: recommendations from the National Tuberculosis Controllers Association and CDC (2005); Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition) (2012); Depression and Suicide Risk in Adults: Screening (2023)</paragraph><paragraph>Follow-up: End-of-treatment visit after the 119th dose. Call the same day for hepatitis symptoms, tendon pain, or a returning cough. Next scheduled visit 1838-07-21: end-of-treatment review after 119 doses. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
